Research Peptides for Sale: The Catalog and Its Documentation Standard

Reviewed August 27, 2026 · Artemis Labs

Artemis Labs carries research peptides for laboratory use — in-vitro, cell-culture, and pre-clinical work. Every compound is supplied as lyophilized powder under a research-use-only label, and every product page is written as a research document: analytical specifications, inline PubMed and DOI citations, and the unfavorable findings alongside the favorable ones. This page is the catalog’s front door, and an explanation of the standard behind it.

What is in the catalog

The catalog covers the compound families researchers actually work with — tissue-repair peptides, mitochondrial and metabolic research compounds, cosmetic-research peptides, and research blends — each on its own documented page:

• Tissue-repair research — the BPC-157 / TB-500 family and related repair-pathway compounds
• Browse all products — the full catalog, each page with its own references section
• The research library — the same literature, organized by research topic instead of by product

The documentation standard, in plain terms

Most peptide storefronts describe their products in marketing language. We think a research catalog should read like a research document, so every Artemis product page holds to five rules:

• Every claim traces to a source. Product pages link claims inline to PubMed or DOI records — roughly 500 citations across the catalog — so you can follow any statement back to the paper it came from.
• Counter-evidence is reported, not buried. Where the published literature contains negative findings for a compound we sell, the product page says so. A 2023 peer-reviewed analysis found marketed peptide products under several trade names misbranded and adulterated (Delcourt et al. 2023, PMID 36482504) — in a market like that, showing you the unfavorable studies is the trust signal.
• Identity is stated precisely. Sequence, molecular weight, CAS number, PubChem CID, and how the compound differs from the molecules it gets confused with. When a widely cited study used a related molecule instead of the compound on the page, the page says that too.
• Findings are reported by model. A result observed in cell culture is described as a cell-culture result; a rodent-model finding is described as one. No page promises outcomes, and no page provides usage guidance of any kind.
• The pages get more thorough over time. When new research supersedes an older claim, the page is updated additively — the record of what changed stays visible, and the reference list grows. A product page here is a living document of the compound’s literature, not a static ad.

Ordering, shipping, and policies

Shipping is flat-rate USPS Ground Advantage at $9.95, free on orders over $300, shipped from the United States. Refund, privacy, and research-use terms are published before checkout — see the FAQ for ordering questions. The catalog contains no administration supplies of any kind: this is a research materials catalog, and its contents are consistent with its label.

Out-of-stock compounds and restock notices

When a compound is out of stock, its product page stays up — the research documentation remains useful either way — and offers an email notice for when it returns. The notice does exactly what it says: one email at restock, nothing else. New compounds are added the same way existing ones are maintained: the page and its references are written first, and the compound goes on sale only once its documentation meets the standard above.

How to evaluate us — or any vendor

The right way to read a page titled “peptides for sale” is skeptically. We wrote the checks we think any buyer should run — citations that resolve, counter-evidence on the page, honest testing statements, no administration supplies, published policies — into an evaluation framework you can apply to any vendor, including this one: Where to buy peptides for research: an evaluation framework. For the category itself — what research peptides are and what the literature does and does not show — start with the plain-language guide.

References

1. Delcourt V, et al. TB500/TB1000 and SGF1000: misbranded and adulterated drugs. 2023. PMID 36482504
2. US FDA — Warning Letters index (research-peptide letters of December 10, 2024 and March 31, 2026, documenting the conduct patterns discussed above). fda.gov
3. Mendias CL, Awan TM. Safety and efficacy of approved and unapproved peptide therapies for musculoskeletal injuries. 2026. PMID 41966639
4. Rahman, et al. Therapeutic peptides in orthopaedics: applications, challenges, and future directions. 2026. PMID 41490200

All products sold by Artemis Labs are for research purposes only. Not for human consumption.